Sunshine Biopharma Inc (SBFM) — Financial Flexibility Index
Sunshine Biopharma Inc (SBFM) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $5.13K) represents 0% of total liabilities ($6.41 Million). Check Sunshine Biopharma Inc (SBFM) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sunshine Biopharma Inc Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Sunshine Biopharma Inc across 19 annual periods. For the full cash flow conversion analysis, see SBFM cash generation efficiency.
Annual Financial Flexibility Index for Sunshine Biopharma Inc (2007–2025)
Year-by-year free cash flow to debt coverage for Sunshine Biopharma Inc. Explore Sunshine Biopharma Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.73x | $-5.16 Million | $-5.33 Million | $7.04 Million | ▲ +49.4% |
| 2024 | -1.45x | $-10.21 Million | $-12.53 Million | $7.06 Million | ▼ -11.2% |
| 2023 | -1.30x | $-7.99 Million | $-8.78 Million | $6.14 Million | ▼ -108.4% |
| 2022 | -0.62x | $-4.94 Million | $-5.25 Million | $7.92 Million | ▲ +32.0% |
| 2021 | -0.92x | $-1.83 Million | $-1.83 Million | $1.99 Million | ▼ -180.1% |
| 2020 | -0.33x | $-656.11K | $-657.30K | $2.00 Million | ▲ +44.8% |
| 2019 | -0.59x | $-494.94K | $-495.80K | $833.53K | ▼ -44.5% |
| 2018 | -0.41x | $-493.96K | $-512.81K | $1.20 Million | ▲ +36.8% |
| 2017 | -0.65x | $-539.80K | $-543.52K | $830.85K | ▲ +42.7% |
| 2016 | -1.13x | $-310.74K | $-314.18K | $274.10K | ▼ -490.1% |
| 2015 | -0.19x | $-244.04K | $-867.64K | $1.27 Million | ▲ +80.9% |
| 2014 | -1.01x | $-533.80K | $-538.60K | $531.00K | ▲ +93.0% |
| 2013 | -14.37x | $-559.61K | $-564.40K | $38.95K | ▼ -135.3% |
| 2012 | -6.11x | $-393.05K | $-393.05K | $64.37K | ▲ +92.9% |
| 2011 | -86.58x | $-297.30K | $-297.30K | $3.43K | ▼ -183.4% |
| 2010 | -30.54x | $-348.32K | $-348.32K | $11.40K | ▼ -4175.9% |
| 2009 | -0.71x | $-10.22K | $-10.22K | $14.31K | ▲ +29.5% |
| 2008 | -1.01x | $-23.03K | $-23.03K | $22.74K | ▲ +51.3% |
| 2007 | -2.08x | $-3.12K | $-3.12K | $1.50K | — |